A data analysis from a randomized clinical trial for stage 3 colon cancer patients by investigators at Dana-Farber Brigham ...

A data analysis from a randomized clinical trial for stage 3 colon cancer patients by investigators at Dana-Farber Brigham ...

The Alliance for Clinical Trials in Oncology today announced the results of a data analysis from a randomized phase III clinical trial involving patients with stage III colon cancer, which found that ...

An investigational blood-based test identified nearly 80% of individuals who had colorectal cancer, according to results of a ...

A novel blood-based test for early detection of colorectal cancer in average-risk adults met the primary endpoints of sensitivity and specificity in the PREEMPT CRC trial.

"Seeing is believing," the founder of lab company Truvian told me. So I tried its tabletop blood testing device—which ...

The government alleges that BioReference submitted claims to federal healthcare programs for blood tests that were not ordered by a patient's provider.

BioReference Health LLC, formerly known as BioReference Laboratories Inc. (BioReference) and OPKO Health Inc. (OPKO), face a ...

BioReference Health LLC, formerly known as BioReference Laboratories Inc., and OPKO Health (OPK) Inc. have agreed to pay $704,349 to resolve ...

A study has examined whether an additional blood test called procalcitonin (PCT) could safely shorten the time children spend on intravenous (IV) antibiotics in hospitals. Despite promising previous ...

(Samuel Martin/CBC) While many teachers who participated in the ATA study said the screening results didn't yield any surprises, Georgiou said early tests on letter identification, vocabulary ...